A study examines how effective the Johnson & Johnson vaccine is against the delta variant of COVID-19.
New Study Raises More Questions About J&J COVID Vaccine
CBS 2 New York
The Delta variant is now responsible for 83% of new COVID cases in the U.S. Now, a preliminary study not yet peer reviewed suggests..
